The results indicate that breast cancer cells treated with the SMRwt peptide displayed decreased function of the human chaperone protein Mortalin, significantly affecting tumor cell proliferation and reducing tumor cell invasion and migration. This evidence concerns the gene HSPA9 and breast cancer.